HOME >> BIOLOGY >> NEWS
Trade, science, risk, precaution: Issues for Seattle

The letter draws on evidence collected as part of the UK's largest ever social science research initiative -- the Global Environmental Change Programme (GECP) of the independent Economic and Science Research Council (ESRC).

"The WTO's current approach to risk issues means that new technologies are effectively assumed safe until proven otherwise. This places excessive faith in our limited knowledge about the safety of new technologies" said Alister Scott, Assistant Director of the GECP and coordinator of the letter. "The opposite is needed: better testing of new products and more thorough monitoring of their effects on the environment and people's health once in use."

"Experiences in the UK suggest that the current approach may lead to what can be described as 'soft disasters' -- large-scale health and environmental problems 'soft disasters' and to avoid undermining public confidence in its decisions".

The researchers will be available for comment and analysis during the Seattle conference. For more details or to arrange interviews with any of the researchers, please contact: Alister Scott, Assistant Director, ESRC Global Environmental Change Programme: Tel: (day) 01273 678986/678935 Fax: 604483 Email: gec@sussex.ac.uk or (home) 01323 811398


'"/>

Contact: Alister Scott
gec@sussex.ac.uk
01273 678986/678935
Economic & Social Research Council
24-Nov-1999


Page: 1

Related biology news :

1. Leading science, higher-education and engineering groups urge six improvements to U.S. visa quagmire
2. Kids gardens grow interest in science, nutrition
3. PNNL science, technology help keep America safe
4. UC Davis science, engineering and technology newstips -- March
5. BRCA mutations not associated with colorectal cancer risk, studies suggest
6. Genetic differences revealed by SNPS play a role in risk, prevention and outcome for cancer
7. Gene increases schizophrenia risk, says study
8. Banning animals from the bedroom could reduce Chagas Disease risk, say Science researchers
9. Some women may have gene sequence that reduces breast cancer risk, SFVAMC study finds
10. Yo-yo dieters show lower levels of "good" cholesterol, could pose heart disease risk, say researchers from national W.I.S.E . study
11. Gel being developed to allow women to control fertility,reduce sexually-transmitted disease risk, including HIV, herpes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Trade science risk precaution Issues for Seattle

(Date:5/23/2013)... in treating cerebral palsy with autologous cord blood. Following ... year old boy had been in a persistent vegetative ... months after treatment with the cord blood containing stem ... the child learned to speak simple sentences and to ... study, dispel the long-held doubts about the effectiveness of ...
(Date:5/23/2013)... fastest growing open-access publishers, announces the launch of ... Biotechnology . , A broad scope journal ... Biotechnology will provide a single open-access platform ... to be disseminated and discussed. , ... an open-science and interactive web platform for the ...
(Date:5/23/2013)... when microbial pathogens are growing increasingly resistant to the ... of Wisconsin scientists has synthesized a potent new class ... staph infections. , Writing online in the Journal ... by University of Wisconsin-Madison chemistry Professor Helen Blackwell describes ... of Staphylococcus aureus , a bacterium at the ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2University of Wisconsin chemists find new compounds to curb staph infection 2
(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...
(Date:5/23/2013)... May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... DCVax ® personalized immune therapies for solid tumor ... at this year,s American Society Of Clinical Oncology (ASCO) ... its leadership role in immune therapy.  (Logo: ... meeting is the pre-eminent conference focused on clinical treatment ...
(Date:5/23/2013)...  Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced that ... at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ... Second Annual Marcum LLP Microcap Conference on Thursday, May ... York City.  The presentation is scheduled to begin at ...
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ... only FDA, Health Canada and CE (Europe) approved Total ... in Scotland, which boasts more than 380,000 visitors annually, ... powered by the Freedom® portable driver as part ... most advanced exhibitions of its kind. , “BodyWorks ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
Cached News: